2. 您的位置
3. 首页
4. 会议论文
5. Preclinical Development of Highly Potent and Non-Toxic HCV Inhibitors with Excellent PK and Solubili

Preclinical Development of Highly Potent and Non-Toxic HCV Inhibitors with Excellent PK and Solubili

来源 :14th international symposium on viral hepatitis and liver di | 被引量 : 0次 | 上传用户：guodianwangxg

【作 者】

：

ZHENG-YUN J.ZHAN 

【机 构】

：

Pharmaceutical Company , 4026 Huaning Rd. Shanghai, 201108,China

【出 处】

：

14th international symposium on viral hepatitis and liver di

【发表日期】

：

2012年8期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Adherence to Hepatitis C Virus Therapy and Early Virologic Outcomes

会议

The Role of General Practitioners and the Associated Challenges in Managing Patients with Chronic He

会议

Effectiveness Of Nucleos(t)ide Analogue Agents For NA-na?ve Patients With Chronic Hepatitis B Virus

会议

Genetic Variation of IL-28B is Associated with Treatment Response of Chronic Hepatitis C

会议

Health-related quality of life during treatment of recent hepatitis C virus infection

会议

Detection of hepatitis C virus after otherwise successful treatment of chronic hepatitis C

会议

Evidence-based e-learning is effective in improving rural and urban primary healthcare workers hepat

会议

Efficacy and dose reduction rate of peg-interferon-α-2a plus ribavirin treatment for elderly patient

会议

Analysis on infection status of Hepatitis B Virus among residents in Hepatitis B prevention and trea

会议

Simultaneous Knockdown of Multiple Ligands of Innate Receptor NKG2D High Efficiently Prevents NK cel

会议